Tanya Siddiqi
Medical professional specializing in CAR T-cell therapy
Best podcasts with Tanya Siddiqi
Ranked by the Snipd community
Dec 1, 2023 • 16min
iwNHL 2023 Session IV: Novel therapies in NHL: BTK inhibitors, BTK degraders, and bispecific antibodies
Tanya Siddiqi and Nirav Shah discuss the role of BTK inhibitors and degraders in NHL. They also explore the growing role of bispecific antibodies in this disease setting. Topics include novel therapies, Perdibrutnib as a non-covalent inhibitor, lessons from a first-in-class bispecific therapy, potential of Biennium-2-M-Amp in DLBCL, and Phase 2 trial findings of Audra Nextermat and Plimotumab.
Jul 25, 2018 • 16min
CAR T-cell therapy: where are we now and what’s in store for the future?
Experts in CAR T-cell therapy discuss the challenges and advancements in the field. Topics include longer follow-up and reversible side effects in the Zuma One trial, promising data in myeloma, complications and management of cytokine release syndrome, strategies for improvement, and the potential of CAR T-cell therapy in diffuse large B cell lymphoma.
